Long‐term strategies for the treatment of Refsum's disease using therapeutic apheresis
Authors:
- 20 January 2012
- journal article
- case report
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 27 (2) , 99-105
Abstract
Refsum's disease is a rare autosomal recessive disorder of fatty acid metabolism. Poorly metabolized phytanic acid accumulates in fatty tissues, including myelin sheaths and internal organs, leading to retinitis pigmentosa, peripheral polyneuropathy, cerebellar ataxia, and renal, cardiac or liver impairment. Dietary restriction of phytanic acid in some cases is not sufficient to prevent acute attacks and stabilize the progressive course. Phytanic acid bound to large low density lipoproteins (LDL) and very low density lipoproteins (VLDL) molecules offers the possibility of extracorporeal elimination by lipid apheresis. We report on the long‐term lipid apheresis treatment of four patients with severe Refsum's disease. Retinitis pigmentosa, peripheral polyneuropathy, cerebellar ataxia, anosmia, and sensorineural hearing loss were major symptoms exhibiting a progressive course. Lipid apheresis was performed for 5–13 years without severe complications. Maximum levels of phytanic acid before commencing chronic lipid apheresis were >300 mg/l. During steady state with lipid apheresis, mean phytanic acid before treatments was 87 mg/l and was reduced to 36 mg/l. Mean reduction rate was 59% per treatment. In all patients, abnormal motor nerve conduction velocity with signs of chronic denervation improved, morphological and functional stabilization of eye involvement was observed. Lipid apheresis prevented the extension of the disease to previously unaffected organs in three patients. Extracorporeal elimination of lipoprotein‐phytanic acid complexes by lipid apheresis represents a pathophysiologically guided therapeutic approach, resulting in long‐term improvement or stabilization of overall rehabilitation in patients with progressive Refsum's disease. J. Clin. Apheresis, 2012.Keywords
This publication has 30 references indexed in Scilit:
- The effectiveness of long-term dietary therapy in the treatment of adult Refsum diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2010
- RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age‐Related Macular DegenerationTherapeutic Apheresis and Dialysis, 2010
- Low‐density Lipoprotein Apheresis Therapy With a Direct Hemoperfusion Column: A Japanese Multicenter Clinical TrialTherapeutic Apheresis and Dialysis, 2006
- Effects of phytanic acid on the vitamin E status, lipid composition and physical properties of retinal cell membranes: implications for adult Refsum diseaseClinical Science, 2001
- Identification of genetic heterogeneity in Refsum's diseaseEuropean Journal of Human Genetics, 2000
- Refsum's disease: long term treatment preserves sensory nerve action potentials and motor function.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Lipapheresis: an immunoglobulin-sparing treatment for Refsum's diseaseActa Neurologica Scandinavica, 1996
- Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis).Journal of Neurology, Neurosurgery & Psychiatry, 1991
- The significance of plasma phytanic acid levels in adults.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- DIETARY EFFECTS ON SERUM-PHYTANIC-ACID LEVELS AND ON CLINICAL MANIFESTATIONS IN HEREDOPATHIA ATACTICA POLYNEURITIFORMISThe Lancet, 1966